Literature DB >> 9893013

Death risk factor analysis in primary hyperparathyroidism.

G Hedbäck1, A Odén.   

Abstract

BACKGROUND: Patients treated for primary hyperparathyroidism run an increased risk of death. The aim of this study was to analyse several factors that may influence their risk of death.
METHODS: General, laboratory, physical and clinical variables, altogether 34 variables, were defined as possible risk factors for death and were studied in a patient series of 845 patients operated on during the period 1953-82. Mean follow-up time was 10.5 years (SD 5.9); 253 patients were deceased at follow-up. Cox's proportional hazard model was used.
RESULTS: We found seven variables with independent influence on the risk of death: age, sex, diabetes, cardiovascular disease, glomerular filtration rate, renal tubular concentration capacity and amount of diseased parathyroid tissue. The remaining 27 variables were separately tested, one at a time, using the same method and with the influence of age and sex eliminated. In this test situation, the year of surgery, peak serum calcium, serum creatinine level, body mass index, hypertension, psychiatric symptoms and a history of crisis were all significantly related to the risk of death. The analyses also gave information on the direction and magnitude of the effect of the variables on the risk of death.
CONCLUSION: Primary hyperparathyroidism itself is a risk factor for death, but it was concluded that well-preserved renal function at surgery seems to have a protective role. We also found that the greater the amount of diseased parathyroid tissue the lesser the renal function and, furthermore, that hyperparathyroidism of substantial degree or long duration may bring about renal impairment that is not necessarily disclosed by the creatinine value alone.

Entities:  

Mesh:

Year:  1998        PMID: 9893013     DOI: 10.1046/j.1365-2362.1998.00387.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  6 in total

1.  The impact of parathyroidectomy on serum ADAMTS1, ADAMTS4 levels, insulin resistance, and subclinical cardiovascular disease in primary hyperparathyroidism.

Authors:  Melia Karakose; Mustafa Caliskan; Muyesser Sayki Arslan; Taner Demirci; Suleyman Karakose; Erman Cakal
Journal:  Endocrine       Date:  2016-11-14       Impact factor: 3.633

2.  CYP2D6, GST-M1 and GST-T1 enzymes: expression in parathyroid gland and association with the parathyroid hormone concentration during early renal replacement therapy.

Authors:  Feng-Xiang Yan; M Chris Langub; Mark A Ihnen; Carlton Hornung; Erkki Juronen; Mary K Rayens; Wei-Min Cai; Peter J Wedlund; Paolo Fanti
Journal:  Br J Clin Pharmacol       Date:  2003-07       Impact factor: 4.335

3.  Serum levels of uric acid and diabetes mellitus influence survival after surgery for primary hyperparathyroidism: a prospective cohort study.

Authors:  Anders Bergenfelz; Anna Bladström; Mark Their; Erik Nordenström; Stig Valdemarsson; Johan Westerdahl
Journal:  World J Surg       Date:  2007-07       Impact factor: 3.352

Review 4.  Persistent and recurrent hyperparathyroidism.

Authors:  Nadine R Caron; Cord Sturgeon; Orlo H Clark
Journal:  Curr Treat Options Oncol       Date:  2004-08

5.  Improvement of hypertension after parathyroidectomy of patients suffering from primary hyperparathyroidism.

Authors:  P D Broulik; A Brouliková; S Adámek; P Libanský; J Tvrdoň; K Broulikova; J Kubinyi
Journal:  Int J Endocrinol       Date:  2011-02-20       Impact factor: 3.257

6.  The effect of parathyroidectomy compared to non-surgical surveillance on kidney function in primary hyperparathyroidism: a nationwide historic cohort study.

Authors:  Josephine Matzen; Lise Sofie Bislev; Tanja Sikjær; Lars Rolighed; Mette Friberg Hitz; Pia Eiken; Anne Pernille Hermann; Jens-Erik Beck Jensen; Bo Abrahamsen; Lars Rejnmark
Journal:  BMC Endocr Disord       Date:  2022-01-06       Impact factor: 2.763

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.